| Product NDC: | 66435-202 |
| Proprietary Name: | Infergen |
| Non Proprietary Name: | Interferon alfacon-1 |
| Active Ingredient(s): | .03 mg/mL & nbsp; Interferon alfacon-1 |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 66435-202 |
| Labeler Name: | Kadmon Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103663 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19971006 |
| Package NDC: | 66435-202-09 |
| Package Description: | 6 VIAL, SINGLE-DOSE in 1 PACKAGE (66435-202-09) > .3 mL in 1 VIAL, SINGLE-DOSE (66435-202-95) |
| NDC Code | 66435-202-09 |
| Proprietary Name | Infergen |
| Package Description | 6 VIAL, SINGLE-DOSE in 1 PACKAGE (66435-202-09) > .3 mL in 1 VIAL, SINGLE-DOSE (66435-202-95) |
| Product NDC | 66435-202 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Interferon alfacon-1 |
| Dosage Form Name | INJECTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 19971006 |
| Marketing Category Name | BLA |
| Labeler Name | Kadmon Pharmaceuticals, LLC |
| Substance Name | INTERFERON ALFACON-1 |
| Strength Number | .03 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Interferon alpha [EPC],Interferon-alpha [Chemical/Ingredient] |